Comparison of risk factors for human metapneumovirus and respiratory syncytial virus disease severity in young children

Journal of Infectious Diseases

Volumn 206, Issue 2, 2012, Pages 178-189

  Papenburg, Jesse ^a,c   Hamelin, Marie Ève ^a   Ouhoummane, Najwa ^b   Carbonneau, Julie ^a   Ouakki, Manale ^b   Raymond, Frédéric ^a   Robitaille, Lynda ^a   Corbeil, Jacques ^a   Caouette, Georges ^a   Frenette, Lyne ^a   De Serres, Gaston ^b   Boivin, Guy ^a  

^a LAVAL UNIVERSITY   (Canada)

^b INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^c MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; BRONCHODILATING AGENT; CORTICOSTEROID;

AGE; BREAST FEEDING; CHILD; CLINICAL STUDY; COHORT ANALYSIS; COMORBIDITY; CROWDING; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FEMALE; FOLLOW UP; GENDER; GENOTYPE; HOSPITALIZATION; HOSPITALIZED CHILD; HOST; HOUSEHOLD; HUMAN; HUMAN METAPNEUMOVIRUS INFECTION; INFANT; INFECTION PREVENTION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MULTIVARIATE ANALYSIS; OXYGEN BREATHING; PEDIATRIC HOSPITAL; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVIEW; RHINOPHARYNGITIS; RISK FACTOR; SCORING SYSTEM; VIRAL RESPIRATORY TRACT INFECTION; VIRUS IDENTIFICATION;

AGE FACTORS; CHILD, PRESCHOOL; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CROWDING; FAMILY CHARACTERISTICS; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; METAPNEUMOVIRUS; PARAMYXOVIRIDAE INFECTIONS; PROSPECTIVE STUDIES; QUEBEC; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 84862842471     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis333     Document Type: Review

References (32)

1. Mathers C, Lopez A, Murray C. The burden of disease and mortality by condition: data, methods, and results for 2001. In: Lopez A, Mathers C, Ezzati M, Jamison D, Murray C, eds. Global burden of disease and risk factors. New York: Oxford University Press and the World Bank, 2006:45-93.
2. Papenburg J, Boivin G. The distinguishing features of human metapneumovirus and respiratory syncytial virus. Rev Med Virol 2010; 20:245-60.
3. van den Hoogen BG, de Jong JC, Groen J, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001; 7:719-24.
4. Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010; 375:1545-55.
5. Williams JV, Edwards KM, Weinberg GA, et al. Population-based incidence of human metapneumovirus infection among hospitalized children. J Infect Dis 2010; 201:1890-8.
6. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009; 360:588-98.
7. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999; 282:1440-6.
8. Stang P, Brandenburg N, Carter B. The economic burden of respiratory syncytial virus-associated bronchiolitis hospitalizations. Arch Pediatr Adolesc Med 2001; 155:95-6.
9. Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1995; 126:212-9.
10. DeVincenzo JP. Factors predicting childhood respiratory syncytial virus severity: what they indicate about pathogenesis. Pediatr Infect Dis J 2005; 24:S177-83, discussion S182.
11. Committee on Infectious Diseases. From the American Academy of Pediatrics: Policy statements-Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics 2009; 124:1694-701.
12. Samson L. Prevention of respiratory syncytial virus infection. Paediatr Child Health 2009; 14:521-32.
13. Gilca R, De Serres G, Tremblay M, et al. Distribution and clinical impact of human respiratory syncytial virus genotypes in hospitalized children over 2 winter seasons. J Infect Dis 2006; 193:54-8.
14. Herfst S, Fouchier RA. Vaccination approaches to combat human metapneumovirus lower respiratory tract infections. J Clin Virol 2008; 41:49-52.
15. Hamelin ME, Gagnon C, Prince GA, et al. Prophylactic and therapeutic benefits of a monoclonal antibody against the fusion protein of human metapneumovirus in a mouse model. Antiviral Res 2010; 88:31-7.
16. Deffrasnes C, Hamelin ME, Prince GA, Boivin G. Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus. Antimicrob Agents Chemother 2008; 52:279-87.
17. Boivin G, De Serres G, Cote S, et al. Human metapneumovirus infections in hospitalized children. Emerg Infect Dis 2003; 9:634-40.
18. Williams JV, Harris PA, Tollefson SJ, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 2004; 350:443-50.
19. Institut de la statistique de Québec. Regional population data: population by age group and sex, 1996-2010. 2011. http://www.stat.gouv.qc. ca/donstat/societe/demographie/dons-regnl/regional/mun-ages.htm. Accessed 12 August 2011.
20. Raymond F, Carbonneau J, Boucher N, et al. Comparison of automated microarray detection with real-time PCR assays for detection of respiratory viruses in specimens obtained from children. J Clin Microbiol 2009; 47:743-50.
21. Wolf DG, Greenberg D, Shemer-Avni Y, Givon-Lavi N, Bar-Ziv J, Dagan R. Association of human metapneumovirus with radiologically diagnosed community-acquired alveolar pneumonia in young children. J Pediatr 2009; 156:115-20.
22. Vicente D, Montes M, Cilla G, Perez-Yarza EG, Perez-Trallero E. Differences in clinical severity between genotype A and genotype B human metapneumovirus infection in children. Clin Infect Dis 2006; 42:e111-3.
23. Agapov E, Sumino KC, Gaudreault-Keener M, Storch GA, Holtzman MJ. Genetic variability of human metapneumovirus infection: evidence of a shift in viral genotype without a change in illness. J Infect Dis 2006; 193:396-403.
24. Semple MG, Cowell A, Dove W, et al. Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. J Infect Dis 2005; 191:382-6.
25. Garcia CG, Bhore R, Soriano-Fallas A, et al. Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis. Pediatrics 2010; 126:e1453-60.
26. Institut National de Santé Publique du Québec. Statistics: proportion of premature births, Québec, Canadian provinces and Canada, 2007. 2010. http://www.inspq.qc.ca/Santescope/element.asp?Lg=en&NoEle=845, Accessed 12 August 2011
27. Jones M, Castile R, Davis S, et al. Forced expiratory flows and volumes in infants. Normative data and lung growth. Am J Respir Crit Care Med 2000; 161:353-9.
28. Law BJ, Langley JM, Allen U, et al. The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr Infect Dis J 2004; 23:806-14.
29. Stokes KL, Chi MH, Sakamoto K, et al. Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice. J Virol 2011; 85:5782-93.
30. Marguet C, Lubrano M, Gueudin M, et al. In very young infants severity of acute bronchiolitis depends on carried viruses. PLoS One 2009; 4:e4596.
31. Martin ET, Kuypers J, Wald A, Englund JA. Multiple versus single virus respiratory infections: viral load and clinical disease severity in hospitalized children. Influenza Other Respi Viruses 2012; 6: 71-7.
32. Kukavica-Ibrulj I, Hamelin ME, Prince GA, et al. Infection with human metapneumovirus predisposes mice to severe pneumococcal pneumonia. J Virol 2009; 83:1341-9.